Ocrelizumab Antibody
Ocrelizumab (IDC-2403) is a humanized anti-CD20 monoclonal antibody used in multiple sclerosis research. It is applied in both in vitro B-cell depletion studies and in vivo models to investigate its mechanisms of action and therapeutic potential against neuroinflammatory diseases.
Product Specifications
Product Name Alternative
IDC2403, IDC-2403, Immunologyrelated, Immunology related, Inflammationrelated, Inflammation related, CD20
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.08 mg/mL
Purity
93.90% (May vary between batches)
Molecular Weight
145.8 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog